Pestalozzi advises SVB Leerink in connection with open market sale agreement with Obseva SA offering up to USD 50m in shares (ATM facility)
Pestalozzi advised SVB Leerink LLC in connection with the entering into an open market sales agreement with Obseva SA, a Swiss clinical-stage biopharmaceutical company with a dual listing at SIX Swiss Exchange and Nasdaq, offering up to USD 50m in shares. SVB Leerink is acting as sole agent in connection with this at the market (ATM) facility. Pestalozzi advised Leerink as to all aspects of Swiss law.